Dr. Sadick leads the analytical department at Precision BioSciences, Inc, a Cell and Gene Therapy Biotherapeutics company in Durham, NC. He previously worked as a principal scientist at Catalent Biological Analytical Services in Morrisville, NC. There he coordinated and oversaw Bioassay, ELISA and Molecular Biology projects. Previously, he managed the Bioassay/Relative Potency team for ten years at Catalent Biologics in Kansas City, MO (formerly Aptuit, Inc). Prior to that, Mike worked for six years at Eli Lilly and Company as a research advisor leading the Bioassay Groups, Molecular Biology and Virology in support of Phase I-III projects, as well as providing guidance for commercial bioassay testing. Before his tenure at Eli Lilly, Dr. Sadick ran bioassay groups for ten years at Genentech in South San Francisco. Dr. Sadick has an extensive background in cellular biology, cellular immunology and receptor signaling, molecular biology and biochemistry. He received his MS and PhD in immunology from the University of Washington in Seattle and his BA in biology from Johns Hopkins in Baltimore.